2002 Cannabis Clinical Trials Concentrates 
The Cannigma
MAY 17, 2022
More than half of cannabis users report the plant increases their creativity. They say cannabis can lower inhibition and self-judgment while allowing you to connect with yourself and a new way of looking at things. Whether or not cannabis impacts creativity is a challenging thing to measure. How cannabis can boost creativity.
The Cannigma
AUGUST 14, 2022
As with all things in cannabis, it depends. There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. Cannabis may also be able to help you reach a flow state, where ideas and focus are effortless. How cannabis can help with focus.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
DECEMBER 12, 2022
Just as THCA in cannabis flower needs to be decarboxylated into the active compound THC, psilocybin is not active until it undergoes a chemical reaction. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. However, like cannabis , the root of this shrub produces many bioactive molecules.
Green Relief
MAY 13, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government still maintains that cannabis is a dangerous drug with no medical value. How does cannabis, and THC , in particular, confer neuroprotective effects?
Green Relief
MAY 12, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government still maintains that cannabis is a dangerous drug with no medical value. How does cannabis, and THC , in particular, confer neuroprotective effects?
Cannabis Law Report
NOVEMBER 24, 2021
Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.
Expert insights. Personalized for you.
128 
Let's personalize your content